We will be attending the American Diabetes Association (ADA) conference Friday through Monday!
ibl-america.com/ada/
Set up a meeting with us, if you would like to connect. We are eager to engage in scientific sessions and expand our network within the diabetes community!
We will be attending the Association of Clinical Scientists (ACS) Meeting tomorrow through Thursday!
clinicalscience.org/meetings…
We look forward to exploring the advances in understanding brain disorders and clinical laboratory practices!
#ACS#Neurodegeneration
Over 35 million U.S. citizens suffer from chronic kidney disease. It is of great importance that we raise awareness and support research of CKD. IBL offers a variety of unique biomarker assays that may be useful in studying CKD.
ibl-america.com/blog/kidney-…#NationalKidneyMonth
Amid all of the uncertainty, it was so impactful to witness researchers and clinicians continuing to demonstrate truly transformative work. IBL is here to support you in any way we can!
Thank you SfN for coordinating Neuroscience 2025! We'll see you in D.C.!
#SfN25
Recent literature reflects growing interest in Uromodulin, an organ-specific protein synthesized exclusively in the renal tubules of the kidney.
IBL will be exhibiting at Kidney Week in Houston, TX. Visit our booth #1843 to learn about Uromodulin.
ibl-america.com/human-uromod…
❤️Mycardial Monday❤️: Titin, as the third myofilament type and the determinant of myocardial passive stiffness, is emerging as a critical element in cardiac health and disease.
Human Titin N-Fragment (Urine) ELISA
ibl-america.com/human-titin-…#HeartMonth#TTN#CardiacDisorders